Los Angeles City Attorney Rocky Delgadillo, in concert with FDA, files criminal charges against two firms found importing and distributing over 70,000 tubes of Chinese-manufactured toothpaste contaminated with diethylene glycol, Delgadillo's office announces March 6. The presidents and vice presidents of both Vernon Sales and Selective Imports Corp. were charged with criminal counts for receiving, selling and delivering an adulterated drug product; the maximum penalty for each count is a $1,000 fine and one year jail-time. Investigators believe the firms distributed 480 tubes of DEG-containing "Cooldent" toothpaste to Los Angeles businesses over the past 12 months, according to a release. FDA began sampling toothpaste imported from China in May 2007 based on reports that DEG-contaminated toothpastes were being exported from China to the Dominican Republic, Panama and Australia ("1The Tan Sheet" May 7, 2007, p. 15)...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
A system of pre-regulatory review consultations for innovative drugs and devices in South Korea has contributed to the accelerated development of such products.
Pediatric Advisory Committee will weigh the FDA's recommendation that routine safety monitoring continue for Merck & Co's Gardasil and Sanofi's Fluzone and Dengvaxia despite a political climate that has been unkind to vaccines.
Insurance trade groups warned that the Big Beautiful Bill destabilize Medicaid and result in the largest ever roll-back in health care coverage in the US.
